LARGO, FL / ACCESSWIRE / March 16, 2020 / Almost one out of every six men across the United States experience some form of urinary incontinence. This stigmatizing condition can rob individuals of ...
The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.
SAN FRANCISCO—Patients can safely continue on clopidogrel therapy while undergoing percutaneous tunneled catheter procedures, researchers reported at the 37th Annual Scientific Meeting of the Society ...
Coloplast A/S is about to launch a new single-use male intermittent catheter featuring new technology designed to reduce the risk of urinary tract infections (UTI). “The Luja device, with its ...
SAN RAMON, Calif., and VILNIUS, Lithuania, BioVentrix, a pioneer of technologies and procedures for less-invasive treatment of heart failure (HF), today announced the first-in-man use of its next ...
CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and first patient cases with the latest advancement in ischemic stroke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback